Nautic Partners Makes Strategic Growth Investment in EmpiRx Health
August 31, 2021
Nautic Partners has made a strategic growth investment in EmpiRx Health, the clinically driven, value-based pharmacy benefit manager (PBM). The capital will support EmpiRx’s expansion of its tech-enabled clinical innovation and care models to broaden market reach and drive improved patient outcomes and cost savings for plan sponsors.
- Buyers
- Nautic Partners
- Targets
- EmpiRx Health
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Nautic Partners Makes Growth Investment in SPS Health
February 4, 2022
Healthcare Services
Nautic Partners has made a strategic growth investment in SPS Health to support the company's continued investment in technology, clinical and operational solutions for post-acute pharmacies and PBMs. The capital from Nautic (from its tenth fund) will help SPS expand its technology-enabled offerings and broaden its reach across long-term care, behavioral health, correctional and other specialty pharmacy markets.
-
One Equity Partners Completes Strategic Investment in InfuCare Rx
January 12, 2022
Healthcare Services
One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.
-
Enhanced Healthcare Partners & Bourne Partners Strategic Capital Acquire Pharmaceutical Associates, Inc.
November 6, 2019
Pharmaceuticals
Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.
-
CGE Partners Invests in Datapharm
February 28, 2022
Pharmaceuticals
CGE Partners has made a growth investment in Datapharm, the UK-based provider of regulatory-driven medicines information and software (including the electronic medicines compendium, emc). The investment will partner with Datapharm's management to accelerate new product development, international expansion, and support strategic acquisitions.
-
Enhanced Healthcare Partners Makes Growth Investment in Janus Health
March 21, 2023
Healthcare Services
Enhanced Healthcare Partners (EHP) announced a strategic growth investment in Janus, a provider of AI-enabled revenue cycle management (RCM) technology. The capital will support Janus' market expansion, product development and go-to-market initiatives to accelerate adoption across health systems and RCM service providers.
-
Nautic Partners Completes Growth Investment in KabaFusion
February 2, 2026
Healthcare Services
Nautic Partners has completed a growth investment in KabaFusion, a national provider of home and alternative-site infusion services. KabaFusion’s clinician-led management team remains significant investors and will continue to lead the company while Novo Holdings exited its investment; the capital will support accelerated growth and expanded access to infusion care nationwide.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.